New natural product based entries to treatment of bacterial respiratory tract infections

Expanding the library of broad-spectrum antibiotics is a central component of combating bacterial respiratory tract infections. By extension, this pursuit is also directed at poverty reduction in the developing world as it is intrinsically linked to infectious diseases. To this end, the proposed project aims at advancing natural products with known activity against multi-drug resistant bacteria towards clinical relevance. We will develop efficient chemical syntheses (total and semi-synthetic routes) to access compounds that are not available through other means for biological and mechanistic investigation. The mechanistic work will be used to guide the development of improved and/or simplified structural analogs that can be used at a lower cost. Understanding how to rationally design complex phenylalanine mimetics and oleane triterpenoid structures in this context provides entries to rational development of new generations of small molecule antibiotics working through the same mechanism. The work is enabled by an interdisciplinary collaboration between synthetic chemists in Sweden and Uganda, natural product chemists in Mexico, and microbiologists in South Africa.

Project ID
SE-0-SE-29-2016-05685_2-285-12182
Activity status
2 - Implementation
Aid type
D02 - Other technical assistance
% to Uganda
100.00

Organisations

Funding
Sweden
Extending
The Swedish Research Council
Implementing
Lunds universitet

Disbursements by fiscal year, quarter

Fiscal year Fiscal quarter Value (USD) Uganda Value (USD)
2017 Q2 70,200.07 70,200.07

Commitments by fiscal year, quarter

Fiscal year Fiscal quarter Value (USD) Uganda Value (USD)
2016 Q3 210,600.21 210,600.21

MTEF projections by fiscal year

Fiscal year Value (USD) Uganda Value (USD)

CRS code %
Medical research (12182) 100.0